McKee Named to TIME 100 - VA Boston Healthcare System
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

VA Boston Healthcare System

 

McKee Named to TIME 100

Dr. Ann McKee, MD, Chief of Neuropathology with microscope.

Dr. Ann McKee, MD, Chief of Neuropathology, VA Boston Healthcare System.

By VA Boston Public Affairs
Friday, April 20, 2018

BOSTON –TIME magazine has named Ann McKee, MD, Chief of Neuropathology, VA Boston Healthcare System, and Director of the BU CTE Center, to the 2018 TIME 100, its annual list of the 100 most influential people in the world. The full list and related tributes appear in the April 30 issue of TIME, available on newsstands on Friday, April 20, and online now at http://time.com/100.  

McKee’s research focuses on the long-term effects of concussion, subconcussion and blast injury in contact sports athletes and military veterans, including Chronic Traumatic Encephalopathy (CTE). Her work has shifted the prevailing paradigm of scientific thought regarding head trauma; she has demonstrated that “mild” head trauma, particularly repetitive mild head trauma, is not just an acute injury - it can provoke a persistent and progressive neurodegeneration, CTE that continues long after the traumatic exposure. McKee has published over 70% of the world’s cases of CTE ever reported and created the Veterans Affairs – Boston University – Concussion Legacy Foundation (VA-BU-CLF) brain bank, the world’s largest repository of brains from individuals exposed to traumatic brain injuries (over 550) and neuropathologically confirmed CTE (over 320).

McKee is a board-certified neurologist and neuropathologist and has published widely on many neurodegenerative diseases. She has provided expert testimony to the Congress and Senate. She is a recipient of the Moore Award from the American Association of Neuropathologists, Ethos Award, Santa Clara University, Spivack  Distinguished Scholar in the Neurosciences, Boston University School of Medicine, Vision Award, Associated Industries of Massachusetts, Neurology Faculty Research Award, Boston University School of Medicine, and Scientific Impact Award from the Center for Neuroscience at the University of Pittsburgh. The Boston Globe recently named her Bostonian of the year.

Dr. Ann McKee examines a brain for signs of Chronic Traumatic Encephalopathy (CTE).

Dr. Ann McKee examines a brain for signs of Chronic Traumatic Encephalopathy (CTE).

McKee completed her undergraduate studies at the University of Wisconsin and received her medical degree from the Case Western Reserve School of Medicine. She completed her residency training in neurology at Cleveland Metropolitan General Hospital and in neuropathology at Massachusetts General Hospital. She was assistant professor of neuropathology at Harvard Medical School until 1993 and is currently professor of neurology and pathology at Boston University School of Medicine. She is also Director of the Neuropathology Core and Associate Director for the Boston University Alzheimer’s Disease Center (BUADC). McKee also directs the brain banks for the BUADC, Framingham Heart Study and Chronic Effects of Neurotrauma Consortium, which are all based at VA Boston.

The list, now in its fifteenth year, recognizes the activism, innovation and achievement of the world’s most influential individuals. TIME editors have said of the list in the past, “The TIME 100 is a list of the world's most influential men and women, not its most powerful, though those are not mutually exclusive terms. While power is certain, influence is subtle. As much as this exercise chronicles the achievements of the past year, we also focus on figures whose influence is likely to grow, so we can look around the corner to see what is coming."

 Follow @TIME for updates about the list on Twitter and at Facebook.com/TIME and #TIME100

Share



Get Updates

Subscribe to Receive
Email Updates